Why This 1 Cannabis Stock Sticks Out Like a Sore Thumb

It was popular for a while to refer to the cannabis space as another dot-com bubble. There were definitely similarities: a new industry full of potential was getting investors exciting, driving up share prices until the bubble burst. Post-legalization, many of the great green hopes touted by early cannabis bulls were up in smoke, to use a tired idiom. But…

Read More

Is Namaste Technologies’ Stock a Buy After Reporting Record Quarterly Revenue?

It once aspired to be “the Amazon of cannabis,” but e-commerce focused marijuana stock Namaste Technologies (TSXV:N) has taken on a manufacturing-based growth strategy that’s beginning to yield impressive results. The company has shaken off its drama-filled past. Operations have returned to strong sequential quarterly sales growth. Actually, the company reported record quarterly revenue in last week’s earnings release. Should…

Read More

TFSA Investors: 3 Reasons to Buy Aphria Stock Today

Cannabis firm Aphria’s (TSX:APHA)(NASDAQ:APHA) stock price rallied to close 9% higher on Monday after W. Andrew Carter, a respected equity analyst at Stifel Financial, upgraded the top marijuana stock from a Hold to a Buy and increased his price target. The analyst’s US$5.90 new price target on APHA shares implied a 26% upside from the company’s previous share price at…

Read More

Buy Alert: Molson Coors (TSX:TPX.B) Might Buy This Pot Stock

Molson Coors Canada Inc. (TSX:TPX.B)(NYSE:TAP) is a Canadian icon.  Last year, it generated more than $10 billion in sales. But there’s a problem: growth has stagnated. Last quarter, revenue declined by 8.7% year over year. “After a corporate restructuring in the fourth quarter of 2019 and a bevy of new products hitting the market in the New Year, Molson Coors…

Read More

Cronos Group (TSX:CRON) Stock: 1 Management Decision That Delays Growth in the U.S. Market

Cronos Group (TSX:CRON)(NASDAQ:CRON) finally reported its delayed fourth0quarter and full-year 2019 results on March 30. Much to investors’ disappointment, the company’s quarterly revenue growth in Canada was negative and massive inventory charges drowned spirits. There’s one more piece of information that could warrant a downward revision to the marijuana firm’s potential revenue growth rate. For a start, this was the…

Read More

Cronos Group Stock Price to Suffer an Earnings Restatement Penalty

Cronos Group (TSX:CRON)(NASDAQ:CRON) stock price fell by 12% early on Wednesday to give up some of its near 13% gains on Tuesday after the marijuana firm said it will effect a 40% charge on its third quarter 2019 revenue and will make a similar adjustment in its restated Q1 2019 earnings results. Cronos will reduce its first-quarter and third-quarter revenues…

Read More

Why the Canopy Growth (WEED) Stock Price Fell 15.5% in February

Marijuana stocks certainly have enough problems these days without adding coronavirus fears to the mix. Canopy Growth (TSX:WEED)(NYSE:CGC) is down almost 40% since January 2019. While it remains a leader in the cannabis industry, times are tough. Canopy Growth has felt the sting of a troubled legalization process in Canada and an oversupply of cannabis. Add to this a general…

Read More

Canopy Growth’s (TSX:WEED) Latest 62% Revenue Growth Isn’t Repeatable

Canopy Growth (TSX:WEED)(NYSE:CGC) stock soared over 15% on Friday after the cannabis firm released a strong earnings report that revealed a 62% sequential net revenue growth to $124 million for its fiscal Q3 2019 ended in December 2019. Such high double-digit growth rates, especially on a sequential quarter-over-quarter basis, deserve a huge celebration and should naturally drive the stock price…

Read More

Aurora Cannabis (TSX:ACB) Revenue Falls 26%: Time to Sell the Stock?

This past week, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) released its earnings for the second quarter of 2020, and they were, predictably, bad. The company reported a 26% drop in net revenue along with a colossal $1.3 billion GAAP net loss. While the net loss was mostly due to a goodwill impairment charge, the company also reported a $80 million adjusted EBITDA loss that…

Read More

ACB (TSX:ACB) Stock: Should You Buy Aurora Cannabis Shares After the Latest News?

The share price of Aurora Cannabis (TSX:ACB)(NYSE:ACB) was halted on February 6 ahead of pending news from the company that came out later that day. After markets closed, the marijuana producer announced significant changes in the C-Suite, launching a major restructuring designed to right the ship and get the business on the path to profitability. CEO Terry Booth is leaving…

Read More